Akeso presents Phase III HARMONi-GI1 trial results in biliary tract cancer at ESMO 2026

Sichuan Kelun-Biotech announces Phase III OptiTROP-Lung04 study results at 2026 ESMO

Zhejiang Wenda Pharma reports positive NHWD-870 HCl oral BET inhibitor Phase II trial results at 2026 ESMO Annual Meeting

Lunit and Summit to apply AI-powered SCOPE IO platform for tumour microenvironment analysis in immuno-oncology development

Galderma secures Chinese approval for Relfydess to treat frown lines

Alnylam reports positive Phase 1b results for brezosiran in Huntington's disease

Zai Lab reports promising Phase 1b results for zocilurtatug pelitecan in small cell lung cancer

Labcorp, Charles River and FDA collaborate on advancing preclinical methods for evaluating drug abuse potential

HUYABIO International reports positive Phase 3 trial results for HBI-8000 and nivolumab combination

Harbour BioMed's batoclimab injection receives Chinese regulatory approval to treat generalised myasthenia gravis

NFL Biosciences secures regulatory approval to launch Phase 2 trial of NFL-102

ProBio's Nanjing biologics manufacturing facility completes Chinese regulatory pre-approval inspection

Lynch Regenerative Medicine's Phase IIb clinical trial of rhPDGF-BB injection cleared by FDA

European Commission approves Novartis' Cosentyx for polymyalgia rheumatica

GSK wins US FDA approval for chronic hepatitis B treatment Hibsago